Regulatory Filings • Dec 23, 2021
Regulatory Filings
Open in ViewerOpens in native device viewer


| Informazione Regolamentata n. 20153-79-2021 |
Data/Ora Ricezione 23 Dicembre 2021 16:00:53 |
Euronext Growth Milan | ||
|---|---|---|---|---|
| Societa' | : | MAPS | ||
| Identificativo Informazione Regolamentata |
: | 155712 | ||
| Nome utilizzatore | : | MAPSN03 - Ciscato | ||
| Tipologia | : | REGEM; 3.1 | ||
| Data/Ora Ricezione | : | 23 Dicembre 2021 16:00:53 | ||
| Data/Ora Inizio Diffusione presunta |
: | 23 Dicembre 2021 16:00:55 | ||
| Oggetto | : | MAPS: MINIMUM TRADING LOT | ||
| Testo del comunicato |
Vedi allegato.

Parma, 23 December 2021
MAPS (MAPS:IM; IT0005364333), Innovative SME listed on Euronext Growth Milan operating in the digital transformation sector, announces that starting from Monday 3 January 2022 the minimum trading lot of the MAPS shares (ISIN IT0005364333) will be equal to 1.
All orders on MAPS shares not executed at the end of the session on December 31, 2021 will be canceled.
Founded in 2002, MAPS is an Innovative SME operating in the digital transformation sector. With its registered office in Parma and with approximately 200 employees, it produces and distributes software for the analysis of big data that allows client companies to manage and analyse large quantities of data and information, helping them make strategic and operational decisions and define new business models. It operates in a context characterised by high growth potential: the global market for digital transformation technologies reached \$1,100 billion in 2018; in 2020, a market of \$1,600 billion is estimated (CAGR 2018-2020 approximately +20%). MAPS operates through 3 business units (Large Enterprise, Healthcare Industry, Gzoom) and has a portfolio of over 400 highly loyal Customers from different markets: Telco, Utilities, Healthcare, Retail, Industry and Public Administration.
Through the Patient Journey line of products, it is a leader in the sector of patient reception in healthcare facilities, presiding over the market with over 1,300 installations, which manage the access paths of over 20 million patients nationwide. The Group invests constantly in R&D. The Research & Solutions division, established in 2016, is responsible for identifying market needs and developing software solutions.
The Group closed 2020 with consolidated revenues of Euro 17.9 million and an EBITDA of Euro 3.4 million. In the last 3 years, MAPS has tripled revenue from proprietary solutions and more than doubled EBITDA. The company is characterised by high levels of recurring revenues: recurring fee revenues represent 28% of consolidated operating revenues in 2020. The Group's organic growth has been accompanied by a significant M&A activity, with the acquisition of IG Consulting (2011), Artexe (2018), Roialty (2019), SCS Computers (2020) and IASI (2021).
Release available on and on www.mapsgroup.it
MAPS T +390521052300 [email protected]
Marco Ciscato – Investor Relations Manager [email protected]
EURONEXT GROWTH ADVISOR BPER Banca | T +390272 74 92 29 [email protected]
INVESTOR RELATIONS & FINANCIAL MEDIA IR Top Consulting | T +390245473884 Maria Antonietta Pireddu, [email protected] │ Federico Nasta, [email protected] Domenico Gentile, [email protected] │ Antonio Buozzi, [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.